Survival of patients with ALS following institution of enteral feeding is related to pre‐procedure oximetry: A retrospective review of 98 patients in a single centre

A retrospective review was carried out on the influence of pre‐procedure respiratory assessment on survival of patients with amyotrophic lateral sclerosis (ALS) requiring nutritional support with either a gastrostomy or a nasogastric feeding tube. Over a five‐year period 98 patients (49 male, 49 female; median age 61 years, range 26–86 years) with ALS were referred for enteral feeding with either radiological inserted gastrostomy (RIG), percutaneous endoscopic gastrostomy (PEG) or nasogastric tube (NG). Case notes review was performed to record patient age, sex, pre‐procedure respiratory assessment, method of enteral feeding and survival post‐procedure. Kaplan‐Meier survival curves were constructed for each group, with Cox regression analyses performed in order to establish the effect of each variable on outcome. Median survival (with 95% confidence intervals) following RIG, PEG and NG was 6.31 months (4.58–8.04 months), 7.13 months (4.81–9.45 months) and 0.95 months (0.00–2.77 months), respectively. The survival advantage between RIG and PEG was not statistically significant (p = 0.50), but for NG versus RIG and PEG groups combined, there was a significant difference (p = 0.03). For patients with normal overnight oximetry, median survival was 8.54 months (3.88–13.21 months), compared to 4.80 months (1.20–8.39 months) in the abnormal oximetry group (p = 0.03; relative risk 1.97). It is concluded that RIG and PEG are equivalent in terms of post‐procedure survival. Abnormal oximetry prior to the procedure is a significant indicator of post‐procedure survival.

[1]  P. Preux,et al.  Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[2]  P. Leigh,et al.  Entristar skin-level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis. , 2004, Radiology.

[3]  P. Leigh,et al.  Nutritional management in MND/ALS patients: an evidence based review , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[4]  S. Kalmijn,et al.  Development and implementation of the Dutch protocol for rehabilitative management in amyotrophic lateral sclerosis , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[5]  J. Rosenfeld,et al.  Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders , 2002, Current opinion in clinical nutrition and metabolic care.

[6]  O. Hardiman,et al.  Amyotrophic lateral sclerosis: enteral nutrition provision--endoscopic or radiologic gastrostomy? , 2002, Radiology.

[7]  A. Al-Chalabi,et al.  Early symptom progression rate is related to ALS outcome: a prospective population-based study. , 2002, Neurology.

[8]  A. Siderowf,et al.  Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival , 2002, Neurology.

[9]  P. Munk,et al.  Radiological percutaneous gastrostomy. , 2001, Clinical radiology.

[10]  J. Rowin,et al.  Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS , 2001, Neurology.

[11]  M. Polkey,et al.  Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. , 2001, Brain : a journal of neurology.

[12]  B. Beaufrère,et al.  Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. , 2001, The American journal of clinical nutrition.

[13]  J. Benditt,et al.  Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS , 2001, Neurology.

[14]  R. Rankin,et al.  Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis , 1999, Journal of Neurological Sciences.

[15]  A. Chiò,et al.  Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS , 1999, Neurology.

[16]  D. Sautereau,et al.  Nutritional status is a prognostic factor for survival in ALS patients , 1999, Neurology.

[17]  R. Sufit,et al.  Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence‐based review) , 1999, Muscle & nerve.

[18]  R. Sufit,et al.  Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) , 1999, Neurology.

[19]  P. Leigh,et al.  Indicators and Prevalence of Malnutrition in Motor Neurone Disease , 1998, European Neurology.

[20]  P. Onorati,et al.  P.28 Percutaneous endoscopic gastrostomy inpatients with amyotrophic lateral sclerosis , 1998 .

[21]  G. Mora,et al.  Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis , 1995, Journal of Neurology.

[22]  S. Beasley,et al.  How to avoid complications during percutaneous endoscopic gastrostomy. , 1995, Journal of pediatric surgery.

[23]  G. Tytgat,et al.  Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. , 1994, Gastrointestinal endoscopy.

[24]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[25]  W. Kingston The Management of Motor Neuron Disease , 1989 .

[26]  J. Antel,et al.  Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). , 1983, Journal of the American Dietetic Association.

[27]  J. Ponsky,et al.  Gastrostomy without laparotomy: a percutaneous endoscopic technique. , 1980, Journal of pediatric surgery.

[28]  P. Preux,et al.  Nutritional assessment and survival in ALS patients. , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[29]  R. Hewer The Management of Motor Neuron Disease , 1995 .

[30]  R. Miller,et al.  Management of bulbar symptoms in amyotrophic lateral sclerosis. , 1987, Advances in experimental medicine and biology.